Bruce G. Allen Investments, LLC Novo Nordisk A S Transaction History
Bruce G. Allen Investments, LLC
- $119 Billion
- Q2 2024
A detailed history of Bruce G. Allen Investments, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 200 shares of NVO stock, worth $23,016. This represents 0.02% of its overall portfolio holdings.
Number of Shares
200
Previous 249
19.68%
Holding current value
$23,016
Previous $32 Million
10.71%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding NVO
# of Institutions
1,990Shares Held
318MCall Options Held
5.23MPut Options Held
4.97M-
Jennison Associates LLC21.2MShares$2.44 Billion1.95% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.68 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.63 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.54 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.44 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $260B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...